205 related articles for article (PubMed ID: 33416213)
1. PRMT5 promotes progression of endometrioid adenocarcinoma via ERα and cell cycle signaling pathways.
Mei S; Ge S; Wang J; Li H; Jing X; Liang K; Zhang X; Xue C; Zhang C; Zhang T
J Pathol Clin Res; 2021 Mar; 7(2):154-164. PubMed ID: 33416213
[TBL] [Abstract][Full Text] [Related]
2. Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.
Duan C; Liu X; Liang S; Yang Z; Xia M; Wang L; Chen S; Yu L
J Cell Mol Med; 2014 May; 18(5):863-74. PubMed ID: 24495253
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated macrophage-derived CXCL8 could induce ERα suppression via HOXB13 in endometrial cancer.
Tong H; Ke JQ; Jiang FZ; Wang XJ; Wang FY; Li YR; Lu W; Wan XP
Cancer Lett; 2016 Jun; 376(1):127-36. PubMed ID: 27018308
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma.
Chakravarty D; Srinivasan R; Ghosh S; Rajwanshi A; Gopalan S
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):535-42. PubMed ID: 18931615
[TBL] [Abstract][Full Text] [Related]
5. Forkhead-box A1 suppresses the progression of endometrial cancer via crosstalk with estrogen receptor α.
Wang J; Bao W; Qiu M; Liao Y; Che Q; Yang T; He X; Qiu H; Wan X
Oncol Rep; 2014 Mar; 31(3):1225-34. PubMed ID: 24452315
[TBL] [Abstract][Full Text] [Related]
6. miR-22 inhibits proliferation and invasion in estrogen receptor α-positive endometrial endometrioid carcinomas cells.
Li S; Hu R; Wang C; Guo F; Li X; Wang S
Mol Med Rep; 2014 Jun; 9(6):2393-9. PubMed ID: 24715036
[TBL] [Abstract][Full Text] [Related]
7. Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma.
Hu G; Zhang J; Zhou X; Liu J; Wang Q; Zhang B
Pathol Res Pract; 2020 Oct; 216(10):153149. PubMed ID: 32853964
[TBL] [Abstract][Full Text] [Related]
8. Rap1GAP inhibits tumor progression in endometrial cancer.
Tamate M; Tanaka R; Osogami H; Matsuura M; Satohisa S; Iwasaki M; Saito T
Biochem Biophys Res Commun; 2017 Apr; 485(2):476-483. PubMed ID: 28196746
[TBL] [Abstract][Full Text] [Related]
9. ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription.
Zeng K; Wu Y; Wang C; Wang S; Sun H; Zou R; Sun G; Song H; Liu W; Sun N; Wei S; Liu W; Su Y; Zhou T; Zhang Y; Zhao Y
Cancer Sci; 2020 Jun; 111(6):2062-2077. PubMed ID: 32279431
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-related receptor-γ regulates estrogen receptor-α responsiveness in uterine endometrial cancer.
Yamamoto T; Mori T; Sawada M; Kuroboshi H; Tatsumi H; Yoshioka T; Matsushima H; Iwasaku K; Kitawaki J
Int J Gynecol Cancer; 2012 Nov; 22(9):1509-16. PubMed ID: 23051957
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer.
Backes FJ; Walker CJ; Goodfellow PJ; Hade EM; Agarwal G; Mutch D; Cohn DE; Suarez AA
Gynecol Oncol; 2016 May; 141(2):312-317. PubMed ID: 26957478
[TBL] [Abstract][Full Text] [Related]
12. Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma.
Sheng Y; Wang H; Liu D; Zhang C; Deng Y; Yang F; Zhang T; Zhang C
Gynecol Oncol; 2016 Jan; 140(1):145-51. PubMed ID: 26597461
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of long noncoding RNA, NEAT1 promotes cell proliferation, invasion and migration in endometrial endometrioid adenocarcinoma.
Li Z; Wei D; Yang C; Sun H; Lu T; Kuang D
Biomed Pharmacother; 2016 Dec; 84():244-251. PubMed ID: 27664948
[TBL] [Abstract][Full Text] [Related]
14. Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.
Watanabe J; Nishizaki R; Jobo T; Kamata Y; Hata H; Nishimura Y; Fujisawa T; Okayasu I; Kuramoto H
Int J Gynecol Pathol; 2004 Jul; 23(3):234-40. PubMed ID: 15213599
[TBL] [Abstract][Full Text] [Related]
15. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
[TBL] [Abstract][Full Text] [Related]
16. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.
Zhang B; Dong S; Li Z; Lu L; Zhang S; Chen X; Cen X; Wu Y
J Transl Med; 2015 Nov; 13():349. PubMed ID: 26541651
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
18. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
19. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.
Al-Dhaheri M; Wu J; Skliris GP; Li J; Higashimato K; Wang Y; White KP; Lambert P; Zhu Y; Murphy L; Xu W
Cancer Res; 2011 Mar; 71(6):2118-28. PubMed ID: 21282336
[TBL] [Abstract][Full Text] [Related]
20. Association of CYP1B1 gene polymorphisms and the positive expression of estrogen alpha and estrogen beta with endometrial cancer risk.
Zhu ZY; Mu YQ; Fu XM; Li SM; Zhao FX
Eur J Gynaecol Oncol; 2011; 32(2):188-91. PubMed ID: 21614911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
